51³Ô¹ÏÍø
author
Subscribe
Digital
Print
July 24, 2026
Subscribe
Digital
Print
Heat
Parliament
China
Latest News
Home Delivery
51³Ô¹ÏÍø
Politics
Society
Crime & Legal
Science & Health
Explainer
History
WORLD
Politics
Crime & Legal
Science & Health
Society
ASIA PACIFIC
Politics
Crime & Legal
Science & Health
Society
BUSINESS
Companies
Economy
Markets
Tech
SPORTS
Sumo
Soccer
Baseball
Basketball
Tennis
Olympics
More sports
OPINION
Editorials
Commentary
Geoeconomic Briefing
Environment
CLIMATE CHANGE
Energy
SUSTAINABILITY
WILDLIFE
EARTH SCIENCE
LIFE
Travel
Digital
Food & Drink
Style & Design
Language
Lifestyle
CULTURE
Film
Books
Music
Art
TV & Streaming
Stage
Entertainment news
COMMUNITY
Voices
Issues
How-tos
Our Lives
My Account
My Bookmarks
Logout
Subscribe for more access
Meta
John Lauerman
BUSINESS
/
Companies
Dec 14, 2022
Takeda to pay up to $6 billion for Nimbus immune-therapy drug
After an initial $4 billion payment upfront, U.S.-based Nimbus is eligible for two additional $1 billion payments based on sales.
WORLD
Mar 12, 2022
WHO exploring when and how to declare end of COVID emergency
Such a declaration would be not just a meaningful symbolic step, and would add momentum to the rollback of many pandemic-era public health policies.
WORLD
May 6, 2021
Vaccines work on this India variant. Experts fret about the next.
As infections surge by more than 300,000 cases for 14 straight days, India¡¯s limited ability to track new mutations emerging from its outbreak is a growing concern for scientists.
WORLD
/
Science & Health
Apr 14, 2021
Vaccine blood-clot side effect puts focus on immune reaction
Health officials are exploring whether and how an immune reaction may occur in people who have received vaccines made by AstraZeneca and Johnson & Johnson.
WORLD
/
Science & Health
Dec 21, 2020
Vaccines don¡¯t mean we¡¯ll see the last of COVID-19, experts warn
Even with the latest technologies, money and might behind the unprecedented global drive to knock out COVID-19, the disease is unlikely to be eliminated any time soon.
ASIA PACIFIC
/
FOCUS
Feb 24, 2020
As pandemic looms, world¡¯s top disease fighter engages Xi in delicate quest for cooperation
Tedros Adhanom Ghebreyesus has perhaps the most thankless job in global public health. As director-general of the World Health Organization, the former Ethiopian health minister is racing against time to prevent a dangerous new coronavirus in China from precipitating a worldwide pandemic.
BUSINESS
Oct 27, 2018
Trump springs globalist surprise with medicare drug-pricing plan
A drug-pricing plan unveiled by the Trump administration has put the U.S. on a path toward policies like those in Europe, where governments use tight cost controls.
BUSINESS
/
Companies
Mar 29, 2018
Takeda shares slide amid $50 billion takeover bid for Shire
Shares of Takeda Pharmaceutical Co. fell the most in nine years after the firm disclosed it is considering a bid for Shire PLC that could approach $50 billion (about ?5.3 trillion), which would be the Japanese company¡¯s biggest takeover ever.
WHAT¡¯S TRENDING
Editors' Picks
Japan scientists identify clusters of protein believed to trigger Alzheimer¡¯s disease
Indian brothers make manga debut in Japan
Japan weighs regulating Pokemon cards amid trading mania
Low-income families in Japan cut food and air conditioning during summer break
Iran strikes on CIA facilities prompt questions about possible Russian role
The sci-fi sensibilities of electronic trio Black Boboi
A perfect storm: Kaze Fujii fans flock to Fuji Rock
Can Japanese comedy get laughs in English? Yoshimoto Kogyo lets the jokes rip
The 180-day locals: Life on Japan¡¯s digital nomad visa
Japan reveals hint of new defense spending target in fiscal blueprint
Podcast
Kabukicho: Tokyo¡¯s ¡®stadium of desire¡¯
Longform
Why Japan¡¯s utility poles won¡¯t be disappearing anytime soon
By
Alex K.T. Martin
SUSTAINABLE 51³Ô¹ÏÍø
SPECIAL SUPPLEMENTS
Sponsored contents planned and edited by JT Media Enterprise Division.
SUPPLEMENTS BINDER